Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tractAlex Ganetsky, David Porter, Noelle V. Frey et al.|Bone Marrow Transplantation|2018Cited by 48
Venous thromboembolism following pegaspargase in adults receiving antithrombin supplementationCraig W. Freyer, Selina M. Luger, Alison W. Loren et al.|Leukemia & lymphoma/Leukemia and lymphoma|2020Cited by 10
Letermovir vs. high-dose valacyclovir for cytomegalovirus prophylaxis following haploidentical or mismatched unrelated donor allogeneic hematopoietic cell transplantation receiving post-transplant cyclophosphamideCraig W. Freyer, Alison W. Loren, Alison Carulli et al.|Leukemia & lymphoma/Leukemia and lymphoma|2022Cited by 10
Tocilizumab Is Highly Active for Severe Steroid-Refractory Acute Graft-Versus-Host Disease of the Gastrointestinal TractAlex Ganetsky, David Porter, Noelle V. Frey et al.|Blood|2016Cited by 4
Clofarabine and Busulfan Myeloablative Conditioning in Allogeneic Hematopoietic Cell Transplantation for Patients With Active Myeloid MalignanciesMatthew P. Connor, Noelle V. Frey, Alison W. Loren et al.|Transplantation and Cellular Therapy|2022Cited by 3